FGAM
Financial Gravity Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1
| Closed | -$24 | – | 2083 |
|
|
2023
Q4 | $24 | Hold |
1
| – | – | ﹤0.01% | 1420 |
|
|
2023
Q3 | $24 | Sell |
1
-29
| -97% | -$696 | ﹤0.01% | 1122 |
|
|
2023
Q2 | $629 | Buy |
+30
| New | +$629 | ﹤0.01% | 950 |
|
|
2022
Q2 | – | Sell |
-576
| Closed | -$2.9K | – | 838 |
|
|
2022
Q1 | $2.9K | Buy |
+576
| New | +$2.9K | 0.08% | 215 |
|
|
2021
Q3 | – | Sell |
-104
| Closed | -$31K | – | 1010 |
|
|
2021
Q2 | $31K | Sell |
104
-17
| -14% | -$5.07K | 0.01% | 706 |
|
|
2021
Q1 | $3.17K | Buy |
+121
| New | +$3.17K | 0.06% | 191 |
|
|
2019
Q4 | – | Sell |
-16
| Closed | – | – | 1700 |
|
|
2019
Q3 | $0 | Buy |
16
+4
| +33% | – | ﹤0.01% | 1569 |
|
|
2019
Q2 | $0 | Sell |
12
-1,209
| -99% | – | ﹤0.01% | 1653 |
|
|
2019
Q1 | $44K | Buy |
+1,221
| New | +$44K | 0.04% | 343 |
|
|
2018
Q3 | $2K | Sell |
47
-11
| -19% | -$468 | ﹤0.01% | 1004 |
|
|
2018
Q2 | $3K | Buy |
58
+30
| +107% | +$1.55K | ﹤0.01% | 912 |
|
|
2018
Q1 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 1260 |
|